https://www.biotechblueprint.com/p/argenxs-22b-immunology-buy-j-andBiotech Blueprinten2026-07-31T11:38:10+00:00argenx's $2.2B Immunology Buy, J&J's In Vivo CAR-T Bet, and the FDA's Adcomm Revival – This Week in Biotech #111